# FDA recall D-709-2015

> **Attix Pharmaceuticals** · Class II · drug recall initiated 2014-11-14.

## Product

Hyaluronic Acid Sodium Salt (Ophthalmic Grade) active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

## Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

## Distribution

Nationwide to compounding pharmacies and research organizations.

## Key facts

- **Recall number:** D-709-2015
- **Recalling firm:** Attix Pharmaceuticals
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2014-11-14
- **Report date:** 2015-04-29
- **Termination date:** 2015-10-07

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Toronto, Canada

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-709-2015

## Citation

> AI Analytics. FDA recall D-709-2015. Retrieved 2026-05-28 from https://api.ai-analytics.org/recall/D-709-2015. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*